Investigators from University of Texas MD Anderson Cancer Center Have Reported New Data on Cell Transplants (A Randomized Phase Iii Study of Pretransplant Conditioning for Aml/mds With Fludarabine and Once Daily Iv Busulfan +/- Clofarabine In ...)

Source :: Stem Cell Week. June 20, 2022, 503
Publication Year :: 2022
Abstract: 2022 JUN 20 (NewsRx) -- By a News Reporter-Staff News Editor at Stem Cell Week -- Researchers detail new data in Transplant Medicine - Cell Transplants. According to news reporting [...]

Subjects :: United States. National Institutes of Health
Genzyme Corp.
Oncology, Experimental
Busulfan -- Research
Stem cells -- Research -- Transplantation
Biotechnology industry -- Research
Cancer -- Research
Stem cell research -- Research
Health
University of Texas. M.D. Anderson Cancer Center

Tools